Last reviewed · How we verify
Apetrol ES
At a glance
| Generic name | Apetrol ES |
|---|---|
| Sponsor | LG Life Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetics and Safety Study of Apetrol ES (PHASE1)
- Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apetrol ES CI brief — competitive landscape report
- Apetrol ES updates RSS · CI watch RSS
- LG Life Sciences portfolio CI